Advanced search
Publication Cover
Patient Preference and Adherence Volume 15, 2021 - Issue
Submit an article Journal homepage
169
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Medical Follow-Up Adherence for Patients on All-Oral Regimen for Multidrug-Resistant Tuberculosis in Shenzhen, China

Hui Li1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of China
,
Hailin Zhang1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of China
,
Juan Xiong2 School of Public Health, Health Science Center, Shenzhen University, Guangdong, People’s Republic of China
,
Yi Wang1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of China
,
Weiyu Wang1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of China
,
Jingjing Wang1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of China
,
Yi Lin1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Peize Zhang1 Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4023-0228
ORCID Icon show all
Pages 1491-1496 | Published online: 05 Jul 2021

References

  • World Health Organization. Global Tuberculosis Report 2020. World Health Organization; 2020.
  • Pontali E, Raviglione MC, Migliori GB. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. Eur Respir Rev. 2019;28:152. doi:10.1183/16000617.0035-2019
  • Walker IF, Shi O, Hicks JP, et al. Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. Eur Respir J. 2019;54(1):1800353. doi:10.1183/13993003.00353-2018
  • World Health Organization. Rapid Communication: Key Changes to Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis (MDR/RR-TB). Geneva: World Health Organization; 2018.
  • World Health Organization. WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization; 2019.
  • Javaid A, Shaheen Z, Shafqat M, Khan AH, Ahmad N. Risk factors for high death and loss-to-follow-up rates among patients with multidrug-resistant tuberculosis at a programmatic management unit. Am J Infect Control. 2017;45(2):190–193. doi:10.1016/j.ajic.2016.07.026
  • Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK, Mistry N. Loss-to-follow-up on multidrug resistant tuberculosis treatment in Gujarat, India: the WHEN and WHO of it. PLoS One. 2015;10(7):e0132543. doi:10.1371/journal.pone.0132543
  • Tupasi TE, Garfin AM, Kurbatova EV, et al. Factors associated with loss to follow-up during treatment for multidrug-resistant tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis. 2016;22(3):491–502. doi:10.3201/eid2203.151788
  • Chang SH, Cataldo JK. A systematic review of global cultural variations in knowledge, attitudes and health responses to tuberculosis stigma. Int J Tuberc Lung Dis. 2014;18(2):168–iv. doi:10.5588/ijtld.13.0181
  • Shenzhen Government Online. About Shenzhen. Available from: http://www.sz.gov.cn/en_szgov/aboutsz/index.html. Accessed June 22, 2021.
  • Southern Metropolis Daily. Annual report of female employment in Shenzhen city. Available from: https://www.sohu.com/a/363916522_161795. Accessed June 22, 2021.
  • Viana PVS, Redner P, Ramos JP. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil. Cad Saude Publica. 2018;34(5):e00048217. doi:10.1590/0102-311X00048217
  • Kassa GM, Teferra AS, Wolde HF, Muluneh AG, Merid MW. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2019;19(1):817. doi:10.1186/s12879-019-4447-8
  • Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK, Das M, Daftary A. “When treatment is more challenging than the disease”: a qualitative study of MDR-TB patient retention. PLoS One. 2016;11(3):e0150849. doi:10.1371/journal.pone.0150849
  • Laurence YV, Griffiths UK, Vassall A. Costs to health services and the patient of treating tuberculosis: a systematic literature review. Pharmacoeconomics. 2015;33(9):939–955. doi:10.1007/s40273-015-0279-6
  • Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health. 2017;17(1):221. doi:10.1186/s12889-017-4089-y
  • Diel R, Vandeputte J, de Vries G, Stillo J, Wanlin M, Nienhaus A. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation. Eur Respir J. 2014;43(2):554–565. doi:10.1183/09031936.00079413
  • Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763–1775. doi:10.1183/09031936.00193413
  • Zhang P, Xu G, Song Y, Tan J, Chen T, Deng G. Challenges faced by multidrug-resistant tuberculosis patients in three financially affluent Chinese cities. Risk Manag Healthc Policy. 2020;13:2387–2394. doi:10.2147/RMHP.S275400
  • Trading Economics. China GDP per capital. Available from: https://tradingeconomics.com/china/gdp-per-capita. Accessed June 22, 2021.
  • Taneja N, Chellaiyan VG, Daral S, Adhikary M, Das TK. Home based care as an approach to improve the efficiency of treatment for MDR tuberculosis: a quasi-experimental pilot study. J Clin Diagn Res. 2017;11(8):Lc05–lc08. doi:10.7860/JCDR/2017/27594.10401
  • China Ministry of Health. The Implementation of Appointment  Services in Public Hospital in China. Available from: http://www.nhc.gov.cn/bgt/s9514/200909/fe1e60fab1a0456cae8a70cadd42ef57.shtml.
  • Shenzhen China. Brief Report of appointment registration in public hospital of Shenzhen. Available from: http://www.sz.gov.cn/szzt2010/sjfb/sjkd/content/post_8811479.html. Accessed June 22, 2021.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.